Shares of Evotec SE (OTCMKTS:EVTCY - Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $4.13 and traded as low as $4.07. Evotec shares last traded at $4.07, with a volume of 29,351 shares traded.
Evotec Trading Up 0.5%
The stock has a market capitalization of $1.39 billion, a P/E ratio of 10.29 and a beta of 0.98. The stock has a 50-day moving average price of $4.13 and a two-hundred day moving average price of $4.02. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
(
Get Free Report)
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Recommended Stories
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
